Head-to-head · WeighScore
Ascend Vitality vs Somi Health
By GLP-1 ScorecardUpdated
Score comparison
Somi Health has the higher recorded score — 68.7/100 to 60.9/100.
Somi Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Somi Health is a telehealth weight-loss provider offering compounded GLP-1 medications - compounded semaglutide and tirzepatide injections plus an oral semaglutide tablet.
Before you choose
Before comparing the headline prices, the Ascend Vitality review and the Somi Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Ascend Vitality vs Woodwork and Bayan Health vs Somi Health compare each of them with another graded program, and the list of alternatives to Ascend Vitality ranks the programs closest to Ascend Vitality on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Lttl review covers one graded close to these two, at 63.5/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Ascend Vitality | Somi Health |
|---|---|---|
| WeighScore | 60.9/100 | 68.7/100 |
| Grade | C | C |
| Site position | #333 | #157 |
| Semaglutide | As low as $89/mo (clinician, medication and shipping included; plan length unpublished, compounded) | $135/mo (3-month plan; any dose; compounded) |
| Tirzepatide | As low as $119/mo (clinician, medication and shipping included; plan length unpublished, compounded) | $165/mo (3-month plan; any dose; compounded) |
| Coverage | Coverage not confirmed for the selected plan | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Publishes separate injection offers and lists oral semaglutide
- Treatment pages say the clinician visit, medication and shipping are included, and you pay only if prescribed
What to consider
- “As low as” rates do not say which plan length, dose or upfront charge they require
- Terms require cancellation at least five business days before the next scheduled charge
Strengths
- Among the lowest compounded prices: semaglutide $135/mo, tirzepatide $165/mo (3-month plan)
- Oral semaglutide tablet option for those who want no injections
- One price at any dose, with the medical visit and shipping included
- LegitScript Approved seal displayed; partnered with 503A pharmacies
- Free 2-5 day shipping; no insurance required
What to consider
- Compounded only - no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
- Homepage advertises a 100% money-back guarantee but Terms state all sales are final, no refunds on medication
- Partner pharmacies are not individually named (material transparency gap)
- No single prescribing medical group named; only affiliated professional entities
- State availability not published; confirmed only during intake
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.